HomeNewsTrendsSportsCOVID-19 impact: IPL 2020 sees over 20% drop in brand value
Trending Topics

COVID-19 impact: IPL 2020 sees over 20% drop in brand value

According to a recently released report by Brand Finance, an independent brand valuation and strategy consultancy, the annual 20-20 cricket tournament has recorded a 22 percent drop in brand value to $4.4 billion.

December 11, 2020 / 19:24 IST
Story continues below Advertisement

The 13th edition of the Indian Premier League (IPL) has seen a drop in its brand value due to the coronavirus impact.

Story continues below Advertisement

The cricket league, which was played behind closed doors between September 19 and November 10, was delayed this year due to the pandemic. The league is usually scheduled between March and May.

According to a recently released report by Brand Finance, an independent brand valuation and strategy consultancy, the annual 20-20 cricket tournament has recorded a 22 percent drop in brand value to $4.4 billion.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show